伊克力西斯(EXEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EXEL 伊克力西斯

已收盘 04-26 16:00:00 EDT

23.70

+0.17

+0.72%

盘后23.70

+0.000.00%

19:55 EDT

最高23.76	最低23.36	成交量156.08万
今开23.50	昨收23.53	日振幅1.68%
总市值69.87亿	流通市值58.63亿	总股本2.95亿
成交额3,692万	换手率0.63%	流通股本2.47亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"伊克力西斯","latestPrice":23.7,"timestamp":1714161600000,"preClose":23.53,"halted":0,"volume":1560811,"hourTrading":{"tag":"盘后","latestPrice":23.7,"preClose":23.7,"latestTime":"19:55 EDT","volume":22823,"amount":540905.54,"timestamp":1714175710994},"delay":0,"floatShares":247364726,"shares":294799955,"eps":0.65,"marketStatus":"已收盘","marketStatusCode":5,"change":0.17,"latestTime":"04-26 16:00:00 EDT","open":23.5,"high":23.755,"low":23.36,"amount":36924592.800032005,"amplitude":0.016787,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.65,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":955425600000,"adjPreClose":23.53,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":23.3203,"preClose":23.53,"latestTime":"09:25 EDT","volume":308,"amount":7185.495239999999,"timestamp":1714137932867},"postHourTrading":{"tag":"盘后","latestPrice":23.7,"preClose":23.7,"latestTime":"19:55 EDT","volume":22823,"amount":540905.54,"timestamp":1714175710994},"volumeRatio":0.882067},"requestUrl":"/m/hq/s/EXEL?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2426265367","title":"伊克力西斯盘中异动 股价大跌5.07%报22.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426265367","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426265367?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:16","pubTimestamp":1712844966,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时16分，伊克力西斯股票出现异动，股价急速跳水5.07%。截至发稿，该股报22.48美元/股，成交量49.46万股，换手率0.16%，振幅3.74%。最近的财报数据显示，该股实现营业收入18.30亿美元，净利润2.08亿美元，每股收益0.65美元，毛利17.58亿美元，市盈率34.62倍。伊克力西斯股票所在的生物技术行业中，整体跌幅为1.08%。该信息摘要如下：摩根大通证券公司：重申Exelixis评级，由优于大市调整至优于大市评级, 目标价27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411221607861e4ff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411221607861e4ff3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426852411","title":"摩根大通证券公司：重申Exelixis(EXEL.US)评级，由优于大市调整至优于大市评级, 目标价27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426852411","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426852411?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:14","pubTimestamp":1712762099,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：重申Exelixis(EXEL.US)评级，由优于大市调整至优于大市评级, 目标价27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102315038b0ae805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102315038b0ae805&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409227686","title":"伊克力西斯盘中异动 早盘股价大跌5.27%报20.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409227686","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409227686?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:30","pubTimestamp":1707316242,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时30分，伊克力西斯股票出现波动，股价大幅跳水5.27%。截至发稿，该股报20.68美元/股，成交量5.0077万股，换手率0.02%，振幅2.59%。最近的财报数据显示，该股实现营业收入18.30亿美元，净利润2.08亿美元，每股收益0.65美元，毛利17.58亿美元，市盈率31.82倍。机构评级方面，在所有20家参与评级的机构中，80%的券商给予买入建议，15%的券商给予持有建议，5%的券商给予卖出建议。伊克力西斯股票所在的生物技术行业中，整体跌幅为0.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722304287e6ed7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722304287e6ed7e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exelixis.com","stockEarnings":[{"period":"1week","weight":0.0462},{"period":"1month","weight":-0.0034},{"period":"3month","weight":0.0637},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2753},{"period":"ytd","weight":-0.0192}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Exelixis, Inc.是一家生物科技公司，致力于研发癌症小分子治疗。公司于1994年11月在特拉华州注册为Exelixis制药股份有限公司，并于2000年2月改为Exelixis股份有限公司。公司的资源、研发、生产专注于COMETRIQ（卡博替尼胶囊，公司全资的多靶点受体酪氨酸激酶抑制剂）。公司目标是将COMETRIQ发展成一项主要的特许肿瘤经营产品，认为COMETRIQ治疗恶化、转移的MTC的批准给实现该目标、树立商业地位提供了一个机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.018713},{"month":2,"riseRate":0.458333,"avgChangeRate":0.015199},{"month":3,"riseRate":0.541667,"avgChangeRate":-0.009275},{"month":4,"riseRate":0.541667,"avgChangeRate":0.053392},{"month":5,"riseRate":0.458333,"avgChangeRate":0.002702},{"month":6,"riseRate":0.541667,"avgChangeRate":0.025957},{"month":7,"riseRate":0.541667,"avgChangeRate":0.05138},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.016155},{"month":9,"riseRate":0.458333,"avgChangeRate":-0.044733},{"month":10,"riseRate":0.541667,"avgChangeRate":-0.015438},{"month":11,"riseRate":0.583333,"avgChangeRate":0.058116},{"month":12,"riseRate":0.666667,"avgChangeRate":0.060039}],"exchange":"NASDAQ","name":"伊克力西斯","nameEN":"Exelixis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伊克力西斯(EXEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伊克力西斯(EXEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伊克力西斯,EXEL,伊克力西斯股票,伊克力西斯股票老虎,伊克力西斯股票老虎国际,伊克力西斯行情,伊克力西斯股票行情,伊克力西斯股价,伊克力西斯股市,伊克力西斯股票价格,伊克力西斯股票交易,伊克力西斯股票购买,伊克力西斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伊克力西斯(EXEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伊克力西斯(EXEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}